Product Name: BID Antibody (FITC), Mouse MAb
Immunogen: Recombinant Human BID protein
Mouse IgG1: Mouse IgG1
Concentration: 10 μl/Test, 0.1 mg/ml
Formulation: Aqueous solution containing 0.5% BSA and 0.09% sodium azide
Preparation: This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human BID and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
Specificity: Human BIDNo cross-reactivity in ELISA withE.coli cell lysate
Application: FCM
CAS NO.: 106612-94-6
Product: GLP-1(7-37)
Storage: This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposa
Caption: Flow cytometric analysis of BID expression on Jurkat cells. The cells were treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714), and then stained with FITC Mouse anti-BID. The fluorescence histograms were derived from gated events w
Background: The BH3 interacting domain death agonist (BID) is a pro-apoptotic member of the Bcl-2 protein family, which contains only the BH3 domain, and is required for its interaction with the Bcl-2 family proteins and for its pro-death activity. BID is important t
PubMed ID:http://jpet.aspetjournals.org/content/189/3/748